Last updated on: 6/17/2008 9:26:00 AM PST
What Is the 1999 Institute of Medicine (IOM) Report?
General Reference (not clearly pro or con)
The Institute of Medicine stated in the Preface of its Mar. 1999 report titled "Marijuana and Medicine: Assessing the Science Base":
"In January 1997, the White House Office of National Drug Control Policy (ONDCP) asked the Institute of Medicine to conduct a review of the scientific evidence to asses the potential health benefits and risks of marijuana and its constituent cannabinoids. That review began in August 1997 and culminated in this report...
Information for this study was gathered through scientific workshops, site visits to cannabis buyers' clubs and HIV/AIDS clinics, analysis of the relevant scientific literature, and extensive consultation with biomedical and social scientists... As a result, roughly equal numbers of persons and organizations opposed to and in favor of the medical use of marijuana were heard from."
The Co-Principal Investigators of the report were John A. Benson, Jr., MD and Stanley J. Watson, Jr., MD, PhD The Study Director was Janet E. Joy, PhD.
Mar. 1999 - Institute of Medicine
"Marijuana and Medicine: Assessing the Science Base" (988 KB)
The US Drug Enforcement Administration (DEA) stated the following on Apr. 4, 2002 regarding the 1999 Institute of Medicine report:
"The Institute of Medicine (under the National Academy of Science) conducted a comprehensive study in 1999 to assess the potential health benefits of marijuana and its constituent cannabinoids."
Apr. 4, 2002 - US Drug Enforcement Administration (DEA)
The Marijuana Policy Project (MPP) described the 1999 Institute of Medicine report on its website (accessed May 11, 2006):
"[T]he Institute of Medicine (IOM) held three hearings on the medical use of marijuana to gather information for its upcoming report, commissioned by the White House Office of National Drug Control Policy...
IOM is part of the National Academy of Sciences, a non-government organization with a reputation for conducting objective research. IOM accepted $1 million to conduct a 'comprehensive review' of 'the health effects and potential medical use of marijuana.'"
May 11, 2006 - Marijuana Policy Project (MPP)
The Office of National Drug Control Policy's (ONDCP) former Director, Barry McCaffrey, wrote in an Apr. 20, 1999 letter to US Secretary of Health and Human Services Donna E. Shalala:
"This IOM study is the most comprehensive summary and analysis of what is known about the use of marijuana and its constituent cannabinoids for medicinal purposes, marijuana's mechanism of action, peer-reviewed literature on the uses of marijuana, and costs associated with various forms of the component chemical compounds in marijuana.
We are hopeful that the discussion of the medical efficacy and safety of cannabinoids can now take place within the context of medicine and science."
Apr. 20, 1999 - Office of National Drug Control Policy (ONDCP)